Trial intelligence / Profile preview

Magnesium for Hemodynamics, Cholesterol, and Glucose Control in ICD Patients

NCT00282659Phase 4Completed

Sponsor
Hartford Hospital
Start
Jan 2006
Primary completion
Jun 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of magnesium in coronary artery disease (CAD), hypertension (HTN), dyslipidemia, diabetes mellitus (DM), sponsored by Hartford Hospital. Started Jan 2006; status: completed.

02

Drugs

magnesium
03

Conditions

coronary artery disease (CAD)hypertension (HTN)dyslipidemiadiabetes mellitus (DM)

Beyond the preview

Go deeper on NCT00282659.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00282659.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call